Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data

BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosravi, Ali, Jayaram, B., Goliaei, Bahram, Masoudi-Nejad, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584997/
https://www.ncbi.nlm.nih.gov/pubmed/31221082
http://dx.doi.org/10.1186/s10020-019-0098-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584997/
https://www.ncbi.nlm.nih.gov/pubmed/31221082
http://dx.doi.org/10.1186/s10020-019-0098-x

Ejemplares similares